Inhibition by albumin of merocyanine 540‐mediated photosensitization of platelets and viruses
- 1 June 1991
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 31 (5), 415-422
- https://doi.org/10.1046/j.1537-2995.1991.31591263196.x
Abstract
The effect of the photosensitizer merocyanine 540 (MC 540) on platelets and on three marker viruses was examined to assess its potential in reducing virus transmission by blood products. The results demonstrated several deleterious effects of MC 540 (4–24 micrograms/mL) on platelet morphology and function in both the absence and presence of light (450- 600 nm). Treatment of washed platelets with MC 540 in the dark resulted in a significant release of serotonin in the absence of added agonist, as well as a diminished response to thrombin as measured in vitro. In addition, photosensitization caused spontaneous platelet aggregation and release of 92 percent of the releasable serotonin without the addition of an agonist. Because photo-treatment of blood products is likely to be performed in a protein-rich medium, the influence of albumin on the phototoxic effects on platelets was assessed. Albumin added to the suspension medium at concentrations greater than or equal to 1.0 percent protected the platelets against the effects of MC 540 in the dark, whereas 5-percent albumin was required for protection against the phototoxic effects of MC 540 on the platelet response to thrombin. The antiviral activity of MC 540 and light was examined by using the lipid-containing viruses herpes simplex virus (HSV) and bacteriophages phi 6 and PM2. Of the lipid-enveloped viruses, HSV was 25 times more photosensitive to MC 540 than was phi 6 (15 micrograms/mL). PM2, which has an internal lipid layer, was almost 300 times less sensitive to MC 540 and light than was HSV. Photoinactivation of φ6 and PM2 (by 18 J/cm2) was completely prevented by the addition of 5-percent albumin to the medium. Under these conditions, HSV was still inactivated but was nearly 200 times less sensitive. Therefore, the addition of albumin to protect platelets from damage induced by treatment with MC 540 and light reduced markedly the inactivation or viruses by such treatment.Keywords
This publication has 22 references indexed in Scilit:
- Photodynamic therapy of viral contaminants with potential for blood banking applicationsTransfusion, 1988
- Inactivation of virus in blood productsTransfusion, 1988
- Increased survival of normal cells during laser photodynamic therapy: Implications for ex vivo autologous bone marrow purgingLife Sciences, 1988
- ANTIVIRAL ACTIVITY OF MEROCYANINE 540Photochemistry and Photobiology, 1987
- Procedures for the inactivation of viruses in clotting factor concentratesAmerican Journal of Hematology, 1986
- Absorption and emission characteristics of merocyanine 540 in microemulsionsJournal of the American Chemical Society, 1983
- Binding of merocyanine 540 to normal and leukemic erythroid cellsCell, 1980
- Merocyanine 540 as a fluorescent probe of membranes: Staining of electrically excitable cellsCell, 1978
- Merocyanine 540 as a fluorescent probe of membranes: Selective staining of leukemic and immature hemopoietic cellsCell, 1978
- Host-cell Reactivation in Mammalian CellsInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1971